Profil
Christina Cameron is currently Director-Investor Relations at Medicago, Inc. and Vice President-Investor Relations at Antibe Therapeutics, Inc. Former roles include Independent Director at Zero Candida Technologies, Inc. from 2024 to 2026, and Investor Relations & Media Contact at Medicenna Therapeutics Corp.
Education includes an undergraduate degree from Wilfrid Laurier University.
Aktive Positionen von Christina Cameron
| Unternehmen | Position | Beginn |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Investor Relations Kontakt | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Christina Cameron
| Unternehmen | Position | Ende |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Investor Relations Kontakt | - |
Ausbildung von Christina Cameron
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Wilfrid Laurier University
Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antibe Therapeutics, Inc.
Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
















